Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Auditor change
Notes underwriting agrmnt
Inv. presentation
Quarterly results
Appointed director

Fibrocell Science, Inc. (FCSC) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/07/2020 15-12B Form 15-12B - Securities registration termination [Section 12(b)]:
12/18/2019 EFFECT Form EFFECT - Notice of Effectiveness:
12/18/2019 EFFECT Form EFFECT - Notice of Effectiveness:
12/18/2019 EFFECT Form EFFECT - Notice of Effectiveness:
12/18/2019 EFFECT Form EFFECT - Notice of Effectiveness:
12/18/2019 EFFECT Form EFFECT - Notice of Effectiveness:
12/18/2019 EFFECT Form EFFECT - Notice of Effectiveness:
12/17/2019 4 KIRK RANDAL J (10% Owner) has filed a Form 4 on Fibrocell Science, Inc.
Txns: Converted 10,282 shares @ $0
Unknown transaction of 80,160 shares @ $3, valued at $240.5k
Converted 291 shares @ $0
Unknown transaction of 2,453 shares @ $3, valued at $7.4k
Converted 169,602 shares @ $0
Unknown transaction of 1,324,328 shares @ $3, valued at $4M
Converted 112,617 shares @ $0
Unknown transaction of 539,337 shares @ $3, valued at $1.6M
Converted 106 convertible preferred @ $0
Converted 3 convertible preferred @ $0
Converted 1,746 convertible preferred @ $0
12/13/2019 4 Smith Marcus E. (Director) has filed a Form 4 on Fibrocell Science, Inc.
Txns: Disposed/sold 534 options to buy @ $75, valued at $40.1k
Disposed/sold 1,600 options to buy @ $82.35, valued at $131.8k
Disposed/sold 1,200 options to buy @ $62.1, valued at $74.5k
Disposed/sold 2,400 options to buy @ $81.6, valued at $195.8k
Disposed/sold 2,400 options to buy @ $14.25, valued at $34.2k
Disposed/sold 6,000 options to buy @ $16.55, valued at $99.3k
Disposed/sold 6,000 options to buy @ $2.36, valued at $14.2k
Disposed/sold 12,000 options to buy @ $1.94, valued at $23.3k
12/13/2019 4 Kirk Julian P. (Director) has filed a Form 4 on Fibrocell Science, Inc.
Txns: Disposed/sold 534 options to buy @ $75, valued at $40.1k
Disposed/sold 1,600 options to buy @ $82.35, valued at $131.8k
Disposed/sold 1,200 options to buy @ $62.1, valued at $74.5k
Disposed/sold 2,400 options to buy @ $81.6, valued at $195.8k
Disposed/sold 2,400 options to buy @ $14.25, valued at $34.2k
Disposed/sold 6,000 options to buy @ $16.55, valued at $99.3k
Disposed/sold 6,000 options to buy @ $2.36, valued at $14.2k
Disposed/sold 12,000 options to buy @ $1.94, valued at $23.3k
12/13/2019 4 St.Clare Christine (Director) has filed a Form 4 on Fibrocell Science, Inc.
Txns: Disposed/sold 667 shares @ $3, valued at $2k
Disposed/sold 534 options to buy @ $52.5, valued at $28k
Disposed/sold 1,600 options to buy @ $82.35, valued at $131.8k
Disposed/sold 1,200 options to buy @ $62.1, valued at $74.5k
Disposed/sold 2,400 options to buy @ $81.6, valued at $195.8k
Disposed/sold 2,400 options to buy @ $16.55, valued at $39.7k
Disposed/sold 6,000 options to buy @ $16.55, valued at $99.3k
Disposed/sold 6,000 options to buy @ $2.36, valued at $14.2k
Disposed/sold 12,000 options to buy @ $1.94, valued at $23.3k
12/13/2019 4 Swirsky Douglas J (Director) has filed a Form 4 on Fibrocell Science, Inc.
Txns: Disposed/sold 534 options to buy @ $56.25, valued at $30k
Disposed/sold 1,600 options to buy @ $82.35, valued at $131.8k
Disposed/sold 1,200 options to buy @ $62.1, valued at $74.5k
Disposed/sold 2,400 options to buy @ $81.6, valued at $195.8k
Disposed/sold 2,400 options to buy @ $14.25, valued at $34.2k
Disposed/sold 6,000 options to buy @ $16.55, valued at $99.3k
Disposed/sold 6,000 options to buy @ $2.36, valued at $14.2k
Disposed/sold 12,000 options to buy @ $1.94, valued at $23.3k
12/13/2019 4 Moore Kelvin (Director) has filed a Form 4 on Fibrocell Science, Inc.
Txns: Disposed/sold 304 shares @ $3, valued at $912
Disposed/sold 534 options to buy @ $232.5, valued at $124.2k
Disposed/sold 534 options to buy @ $52.5, valued at $28k
Disposed/sold 1,600 options to buy @ $82.35, valued at $131.8k
Disposed/sold 1,200 options to buy @ $62.1, valued at $74.5k
Disposed/sold 2,400 options to buy @ $81.6, valued at $195.8k
Disposed/sold 2,400 options to buy @ $14.25, valued at $34.2k
Disposed/sold 6,000 options to buy @ $16.55, valued at $99.3k
Disposed/sold 6,000 options to buy @ $2.36, valued at $14.2k
Disposed/sold 12,000 options to buy @ $1.94, valued at $23.3k
12/13/2019 4 Maslowski John Michael (CEO) has filed a Form 4 on Fibrocell Science, Inc.
Txns: Disposed/sold 3,164 shares @ $3, valued at $9.5k
Disposed/sold 908 options to buy @ $232.5, valued at $211.1k
Disposed/sold 1,167 options to buy @ $82.35, valued at $96.1k
Disposed/sold 1,334 options to buy @ $74.25, valued at $99k
Disposed/sold 1,334 options to buy @ $44.1, valued at $58.8k
Disposed/sold 6,668 options to buy @ $52.95, valued at $353.1k
Disposed/sold 6,667 options to buy @ $34.05, valued at $227k
Disposed/sold 16,667 options to buy @ $9.94, valued at $165.7k
Disposed/sold 20,000 options to buy @ $3.45, valued at $69k
Disposed/sold 100,000 options to buy @ $1.78, valued at $178k
12/13/2019 4 Mazur Marc (Director) has filed a Form 4 on Fibrocell Science, Inc.
Txns: Disposed/sold 600 shares @ $3, valued at $1.8k
Disposed/sold 534 options to buy @ $390, valued at $208.3k
Disposed/sold 534 options to buy @ $232.5, valued at $124.2k
Disposed/sold 534 options to buy @ $52.5, valued at $28k
Disposed/sold 1,600 options to buy @ $82.35, valued at $131.8k
Disposed/sold 1,200 options to buy @ $62.1, valued at $74.5k
Disposed/sold 2,400 options to buy @ $81.6, valued at $195.8k
Disposed/sold 2,400 options to buy @ $14.25, valued at $34.2k
Disposed/sold 6,000 options to buy @ $16.55, valued at $99.3k
Disposed/sold 6,000 options to buy @ $2.36, valued at $14.2k
Disposed/sold 12,000 options to buy @ $1.94, valued at $23.3k
12/13/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/13/2019 4 Buckley Sean D. (CFO) has filed a Form 4 on Fibrocell Science, Inc.
Txns: Disposed/sold 200 options to buy @ $232.5, valued at $46.5k
Disposed/sold 334 options to buy @ $82.35, valued at $27.5k
Disposed/sold 1,000 options to buy @ $63.6, valued at $63.6k
Disposed/sold 2,229 options to buy @ $11.25, valued at $25.1k
Disposed/sold 4,000 options to buy @ $11.25, valued at $45k
Disposed/sold 5,000 options to buy @ $3.45, valued at $17.3k
Disposed/sold 30,000 options to buy @ $1.78, valued at $53.4k
Disposed/sold 15,000 options to buy @ $1.82, valued at $27.3k
12/13/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/13/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/13/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/13/2019 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/13/2019 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/13/2019 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/13/2019 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/13/2019 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/13/2019 POS AM Form POS AM - Post-Effective amendments for registration statement:
12/13/2019 S-8 POS Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments:
12/13/2019 25-NSE Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities:
12/13/2019 8-K Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Sta...
Docs: "Amended and Restated Certificate of Incorporation of the Company",
"Amended and Restated Bylaws of the Company"
12/10/2019 8-K Quarterly results
11/14/2019 10-Q Quarterly Report for the period ended September 30, 2019
11/12/2019 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
10/28/2019 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
10/11/2019 PREM14A Form PREM14A - Preliminary proxy statements relating to merger or acquisition:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy